GlobeNewsWire
06 Nov 2025, 21:01 UTC · 47w ago
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
Verdict
Headline takes no side. We score PCRX +0.80 — strongly bullish.
- Expected · PCRX
+0.80strongly bullish
−1 bearish0bullish +1More positive than 87% of ticker scores this week
- Actual





